· Venture Capital Tracker · investment-strategies

EGIDE's €8M Seed: France Doubles Down on Counter-Drone Capability

EGIDE's Paris seed round is a microcosm of France's push for sovereign counter-UAV systems and dual-use defense tech.

EGIDE's €8M Seed: France Doubles Down on Counter-Drone Capability

Paris-based EGIDE raised an €8M seed in March 2026, per Vestbee, for drone countermeasures and C-UAS technology.

The problem this startup is attacking

Low-cost commercial and weaponized drones are reshaping battlefield and critical infrastructure security. Affordable, deployable C-UAS systems (detect, track, neutralize) are under-supplied.

Why this is a live problem now

  • Conflicts since 2022 have shown drones are cheap to deploy, expensive to defend against.
  • Airports, stadiums, and critical sites face real drone-incursion incidents.
  • European ministries want sovereign C-UAS options at scale.

Competitive map

  • Dedrone (acquired by Axon).
  • D-Fend Solutions, Anduril Pulsar / Sentry.
  • Thales and MBDA larger programs.

Market signal (the number to remember)

  • Seed-stage C-UAS funding with European state interest is a credible 2026 defense investment area.

Practical takeaway (operator + investor)

  1. Operators: Targeting French DGA and allied ministries with clear interoperability stories is a workable early GTM.
  2. Investors: Expect more €5–25M seed/Series A rounds in European C-UAS, EW, and autonomous ground systems.

Sources

  1. Vestbee March 2026: https://vestbee.com/insights/articles/top-european-funding-rounds-closed-in-march-2026

Follow Venture Capital Tracker in Google

Add VCT as a preferred source to make our venture-capital coverage easier to find in Google Search.

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »